hypothesis glutathione persister cells Drug-tolerant cancer are vulnerable to GPX4 inhibition Exploiting phenotypic heterogeneity to improve

Exploiting phenotypic heterogeneity to improve production of glutathione by yeast Microbial Cell Factories Springer Nature Link Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies PMC GPX4 in cell death, autophagy, and disease PMC Vaccinia related kinase 2 inhibition elicits vulnerability of glutathione metabolism in pancreatic cancer Cell Death & Disease Persister cancer cells: Iron addiction and vulnerability to ferroptosis: Molecular Cell Drug tolerant persister cancer cells are vulnerable to GPX4 inhibition Nature

SKU: 38313632094 · From uitvaartzorgvdb.be